Table 2 Clinical characteristics of the patients

Satisfaction

3.3 ± 1.6

2.5 ± 1.8

< 0.001

2.7 ± 1.8

2.2 ± 1.7

2.5 ± 1.9

0.344

Effect

3.1 ± 1.6

2.4 ± 1.6

< 0.001

2.6 ± 1.6

2.2 ± 1.5

2.4 ± 1.7

0.366

PHQ-15

8.0 ± 4.8

12.0 ± 5.5

< 0.001

12.0 ± 6.1

10.7 ± 5.0

13.1 ± 5.6

0.019^c

WHO DAS 2.0

17.3 ± 5.8

22.7 ± 8.5

< 0.001

21.3 ± 8.0

21.1 ± 6.8

24.8 ± 9.8

0.006^b,c

PHQ-9

6.8 ± 5.8

11.8 ± 6.8

< 0.001

10.4 ± 7.9

11.0 ± 6.0

13.4 ± 6.8

0.012^b,c

GAD-7

5.1 ± 5.2

9.7 ± 6.1

< 0.001

7.8 ± 6.3

9.0 ± 5.6

11.1 ± 6.3

0.004^b,c

WI-7

13.2 ± 5.5

21.4 ± 7.4

< 0.001

18.6 ± 7.3

20.7 ± 6.9

23.3 ± 7.2

0.001^b,c

SSD-12

9.1 ± 9.4

23.6 ± 11.4

< 0.001

17.8 ± 10.8

22.1 ± 10.2

27.5 ± 10.9

< 0.001^a,b,c

SSS-8

7.0 ± 5.1

12.0 ± 6.5

< 0.001

11.6 ± 7.0

10.8 ± 5.3

13.3 ± 7.0

0.034^c

SF-12 (PCS)

45.1 ± 8.6

39.1 ± 9.0

< 0.001

41.0 ± 8.2

40.0 ± 9.0

37.4 ± 9.0

0.038^b

SF-12 (MCS)

44.6 ± 11.5

34.9 ± 11.3

< 0.001

38.6 ± 13.9

34.4 ± 11.6

33.5 ± 9.8

0.044^b

Number of visits

1.8 ± 0.9

2.2 ± 1.1

< 0.001

1.9 ± 1.0

1.9 ± 1.0

2.6 ± 1.0

< 0.001^a,b,c